Sulbactam sodium

舒巴坦钠

Report date: 2024/01/18 15:14:48
NME

Base Information

Drug NameSulbactam sodium
Drug Alias Name舒巴克坦钠青霉烷砜钠舒巴坦CombactamCP-45899-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1991/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHarbin Pharmaceutical Group Co Ltd General Pharm Factory
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Pharmaceutical Group Co Ltd General Pharm Factory
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CG01
Related LinksWikipediaDrugBankKEGG